Oberlender, R; Nichols, DE. (+)-N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxymethamphetamine-like behavioral activity J. Pharmacol. Exp. Ther., 1 Dec 1990, 255 (3), 1098–1106. 1.9 MB. #MDMAI
Monte, AP; Marona-Lewicka, D; Cozzi, NV; Nichols, DE. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine J. Med. Chem., 1 Nov 1993, 36 (23), 3700–3706. 1.0 MB. https://doi.org/10.1021/jm00075a027 MS,NMR
Sainsbury, PD; Kicman, AT; Archer, RP; King, LA; Braithwaite, RA. Aminoindanes—the next wave of ‘legal highs’? Drug Test. Anal., 1 Aug 2011, 3 (7–8), 479–482. 79 kB. https://doi.org/10.1002/dta.318 #MDMAI
2-Amino-5,6-methylenedioxytetralin · 5,6-MDAT
2-Amino-6,7-methylenedioxytetralin · 6,7-MDAT
4,5-MDMAI · 4,5-Methylenedioxy-2-(methyllamino)indane
Hydrohydrastinine · MDHM-4
β-H2C-MDA · β-Methylidene-3,4-methylenedioxyamphetamine
2,5-DMeA NS · 2,5-Dimethyl-β-methyl-β-nitrostyrene
3,5-Dimethyl-β-methyl-β-nitrostyrene
3,4-Dimethyl-β-methyl-β-nitrostyrene
2,6-Dimethyl-β-methyl-β-nitrostyrene
2,4-Dimethyl-β-methyl-β-nitrostyrene
2,3-Dimethyl-β-methyl-β-nitrostyrene